Vitamin D has been shown in studies to be a powerful inhibitor of renal neovascularization and to reduce vascular endothelial growth factor (VEGF) production, indicating its role in the pathogenesis of diabetic nephropathy. The gene discussed is VEGFA; the disease is diabetic kidney disease.